7946573

Source:http://linkedlifedata.com/resource/pubmed/id/7946573

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006772, umls-concept:C0014582, umls-concept:C0040979, umls-concept:C0086409, umls-concept:C0205179, umls-concept:C0281361, umls-concept:C0441655, umls-concept:C0679729, umls-concept:C1257890, umls-concept:C1999216
pubmed:issue	7
pubmed:dateCreated	1994-12-12
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9005373
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Trifluoperazine
pubmed:status	MEDLINE
pubmed:issn	0959-8049
pubmed:author	pubmed-author:AbadAA, pubmed-author:BalañáCC, pubmed-author:CampsCC, pubmed-author:FongLL, pubmed-author:MasutiBB, pubmed-author:SánchezJ JJJ, pubmed-author:VicensJ LJL
pubmed:issnType	Print
pubmed:volume	30A
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1043
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:7946573-Adenocarcinoma, pubmed-meshheading:7946573-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7946573-Drug Resistance, Multiple, pubmed-meshheading:7946573-Epirubicin, pubmed-meshheading:7946573-Female, pubmed-meshheading:7946573-Humans, pubmed-meshheading:7946573-Male, pubmed-meshheading:7946573-Middle Aged, pubmed-meshheading:7946573-Pancreatic Neoplasms, pubmed-meshheading:7946573-Trifluoperazine
pubmed:year	1994
pubmed:articleTitle	Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
pubmed:publicationType	Letter